We selected certain endpoints that have been consistently shown to be altered by TCE and AIH development in previous investigations including CD4 cytokines (e.g., IFN-γ, markers of liver inflammation, regeneration/repair, and proliferation, as well as intestinal microbiome and cytokines). The gene discussed is CD4; the disease is autoimmune hepatitis.